2m 2m 2m 2m 2m 2m 2m
PALISADE BIO (PALI)
NASDAQ
$1.91+$0.05 (+2.69%)
Price as of Jun 03, 2026 7:12 PM EDT- $368.0MMarket Cap
- 152.72%1-Year Change
- BiotechnologyIndustry
PALISADE BIO (PALI)
$1.91+$0.05 (+2.69%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
B GROUP, INC. | 6.58% | 11.4M | +6.9M (+60.58%) | Mar 31, 2026 |
JANUS HENDERSON GROUP PLC | 6.16% | 10.7M | +149,118 (+1.40%) | Mar 31, 2026 |
OCTAGON CAPITAL ADVISORS LP | 5.92% | 10.3M | +708,419 (+6.89%) | Mar 31, 2026 |
PERCEPTIVE ADVISORS LLC | 5.14% | 8.9M | -3.1M (-34.97%) | Mar 31, 2026 |
AMERIPRISE FINANCIAL INC | 5.02% | 8.7M | +1.8M (+20.66%) | Mar 31, 2026 |
COMMODORE CAPITAL LP | 4.14% | 7.2M | -4.3M (-59.38%) | Mar 31, 2026 |
RA CAPITAL MANAGEMENT, L.P. | 4.10% | 7.1M | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Simplify Exchange Traded Funds | 0.20% | 350,000 | +350,000 (+100.00%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 0.07% | 126,259 | 0 (0.00%) | Feb 28, 2026 |
FIDELITY COMMONWEALTH TRUST | 0.05% | 81,930 | 0 (0.00%) | Feb 28, 2026 |
VANGUARD INDEX FUNDS | 0.04% | 77,553 | 0 (0.00%) | Mar 31, 2026 |
Virtus Investment Trust | 0.03% | 46,000 | 0 (0.00%) | Mar 31, 2026 |
EMPOWER FUNDS, INC. | 0.03% | 44,447 | -19,239 (-43.29%) | Mar 31, 2026 |
BRIDGEWAY FUNDS INC | 0.002% | 4,104 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions283.2M (87.88%)
- Mutual Funds36.5M (11.32%)
- Insiders2.6M (0.80%)
- Other0 (0.00%)
Insider Transactions
- 0.80% (2.6M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $10,941.27Amount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $41,049.75Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Finley John David CEO, CFO | Sell | Feb 12, 2026 | $6,818.00 | 3,896 | $1.75 | 27,353 |
Finley John David CEO, CFO | Exempt | Feb 11, 2026 | $0.00 | 13,333 | $0.00 | 26,667 |
Finley John David CEO, CFO | Exempt | Feb 11, 2026 | $0.00 | 13,333 | $0.00 | 31,249 |
Finley John David CEO, CFO | Award | Feb 09, 2026 | $0.00 | 2.0M | $0.00 | 2.0M |
Williams Donald Allen | Buy | Jan 16, 2026 | $8,356.00 | 5,000 | $1.67 | 10,728 |
Williams Donald Allen | Buy | Jan 09, 2026 | $9,400.00 | 5,000 | $1.88 | 5,728 |
Finley John David CEO, CFO | Award | Oct 06, 2025 | $0.00 | 9.2M | $0.00 | 9.2M |
Jones Mitchell Lawrence Chief Medical Officer | Award | Oct 06, 2025 | $0.00 | 7.7M | $0.00 | 7.7M |
Chuang Emil | Award | Jul 18, 2025 | $0.00 | 8,000 | $0.00 | 8,000 |
Finley John David CEO, CFO | Award | Feb 11, 2025 | $0.00 | 47,000 | $0.00 | 47,000 |
Jones Mitchell Lawrence Chief Medical Officer | Award | Feb 11, 2025 | $0.00 | 29,000 | $0.00 | 29,000 |
Finley John David CEO, CFO | Award | Feb 11, 2025 | $0.00 | 40,000 | $0.00 | 40,000 |
Jones Mitchell Lawrence Chief Medical Officer | Award | Feb 11, 2025 | $0.00 | 24,000 | $0.00 | 24,000 |
Williams Donald Allen | Exempt | Jun 11, 2024 | $0.00 | 340 | $0.00 | 340 |
Wei Binxian | Exempt | Jun 11, 2024 | $0.00 | 465 | $0.00 | 467 |